Q-PHARM DENIES TRIAL ALLEGATIONS

Q-PHARM DENIES TRIAL ALLEGATIONS

A HERSTON-BASED contract research company has denied an association with clinical trial consultancy Rewards for Research, following controversy surrounding alleged financial incentives for volunteers.

The Sunday Telegraph reported that Rewards for Research advertises on Facebook to attract young people as human guinea pigs, listing Q-Pharm as a client.

Under the National Health and Medical Research Council’s (NHMRC) ethical conduct rules, payments to volunteers should not be disproportionate to time involved or encourage participants to take risks.

It is alleged that the South Brisbane-based Rewards for Research had advertised for clinical trials worth up to $2000 for participants in some cases.

But Q-Pharm CEO Terry Hurst told brisbanebusinessnews.com.au that the consultancy was only a client for one trial between 2006 and 2007 and that his company had since severed ties with the organisation.

“They are not a client of ours and they’re not a company we’ve chosen to be associated with,” says Hurst.

“Volunteers, particularly in early phase trials, are reimbursed for their out-of-pocket expenses, as well as for their time and inconvenience. Reimbursements are generally less than the minimum wage.”

Hurst declined to comment on Q-Pharm’s current volunteer recruitment policies, but affirms they are ‘ethically approved’ and follow NHMRC guidelines.

Get our daily business news

Sign up to our free email news updates.

 
Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

Nick Scali shares reach all-time high following UK expansion plans

Nick Scali shares reach all-time high following UK expansion plans

Nick Scali’s (ASX: NCK) plans to expand into the UK have...

Super Retail Group to face court over allegations of undisclosed exec relationship, bullying

Super Retail Group to face court over allegations of undisclosed exec relationship, bullying

The board of Super Retail Group (ASX: SUL) has announced today that...

Aussie-founded sleep device giant ResMed sees profit lift 29pc

Aussie-founded sleep device giant ResMed sees profit lift 29pc

Shareholders backing Australian-founded, California-based sleep med...

“Difficult decision”: Atlassian co-CEO Scott Farquhar to step down

“Difficult decision”: Atlassian co-CEO Scott Farquhar to step down

After 23 years as co-CEO of Sydney-headquartered software giant Atl...